COMMUNIQUÉS West-GlobeNewswire

ObsEva Announces Pricing of Follow-on Public Offering
20/06/2018
Geneva, Switzerland and Boston, MA - June 20, 2018 - ObsEva SA (NASDAQ: OBSV), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions [...]
Solon Eiendom ASA : Primary insider notification
20/06/2018
(Oslo, Norway, June 19, 2018) UFI AS has today bought 74.688 shares in Solon Eiendom ASA at a price of NOK 29.7396 per share. Solon Eiendom ASA Board Member Øystein A. Landvik owns 33,34 % of the shares in UFI AS. [...]
Publication of offer document by Nordic Transport Group Holding A/S
20/06/2018
Company Announcement 20 June 2018 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH [...]
Shire plc : Rule 2.9 Announcement
20/06/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 20 June 2018 Shire [...]
ERYTECH to Present at JMP Securities Life Science Conference
20/06/2018
LYON, France, June 20, 2018 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext Paris:ERYP) (Nasdaq:ERYP) , a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug [...]
Idorsia initiates PRECISION - Phase 3 study with aprocitentan for resistant hypertension management
20/06/2018
Idorsia to host an investor webcast to discuss the Phase 3 program today at 14:00hrs CEST Allschwil, Switzerland - June 20, 2018 Idorsia Ltd (SIX: IDIA) today announced that the first patient has been enrolled into [...]
argenx reports interim data from first cohort of Phase 2 proof-of-concept clinical trial of efgartigimod for the treatment of pemphigus vulgaris
20/06/2018
Rapid disease control observed in 4/6 patients Strong PD effect correlates with improvement in PDAI score Favorable tolerability profile; Independent Data Monitoring Committee (IDMC) recommends advancing to cohort 2 [...]
iTeos Therapeutics Completes $75 Million Series B Financing
20/06/2018
iTeos Therapeutics Completes $75 Million Series B Financing Oversubscribed financing round led by new U.S. investor MPM Capital Proceeds to support accelerated development of innovative next-generation immuno-oncology [...]
Emerald Health Therapeutics Welcomes Historic Passing of Bill C-45 to Legalize Adult-Use Cannabis in Canada
20/06/2018
VICTORIA, British Columbia, June 19, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (TSXV:EMH) (OTCQX:EMHTF) (Emerald) today applauds the Canadian government’s historic passing of Bill C-45 (Cannabis Act) to [...]
The Ensign Group Acquires Office Building in Orange County, California
20/06/2018
MISSION VIEJO, Calif., June 19, 2018 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (NASDAQ:ENSG), the parent company of the Ensign™ group of skilled nursing, rehabilitative care services, home health care, hospice care and [...]
MediciNova Receives Notice of Allowance for New Patent Covering MN-001 for the Treatment of Hypertriglyceridemia and Hypercholesterolemia in Japan
20/06/2018
LA JOLLA, Calif., June 19, 2018 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number:4875), [...]
Trillium Therapeutics Announces “At-The-Market” Issuance Program and Filing of Prospectus Supplement
20/06/2018
TORONTO, June 19, 2018 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. (NASDAQ:TRIL) (TSX:TRIL) (“Trillium” or the “Company”), a clinical stage immuno-oncology company developing innovative therapies for the treatment of [...]
Vigil Health Solutions Reports Record Sales Bookings for Fiscal 2018
19/06/2018
VICTORIA, British Columbia, June 19, 2018 (GLOBE NEWSWIRE) -- Vigil Health Solutions Inc. (“Vigil”) (TSX-V:VGL) announces the results of operations for the fiscal year and the fourth quarter, ending March 31, 2018. [...]
RespireRx Pharmaceuticals Inc. Announces Resignation of Dr. James S. Manuso
19/06/2018
Glen Rock, N.J, June 19, 2018 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. announces the decision of Dr. James S. Manuso to resign as president, CEO, Vice Chairman and member of the Board of Directors (“Board”) of [...]
CORRECTING and REPLACING -- Pascal Biosciences Engages CFN Media to Build New Investor Audience -- CFN Media
19/06/2018
SEATTLE, June 19, 2018 (GLOBE NEWSWIRE) -- In a release issued today under the same headline by CFN Media, please be advised that the compensation that Pascal has made for CFN Media has been added to the About CFN Media [...]
Prothena Announces Phase 1b Clinical Trial Results of PRX002/RG7935 for Parkinson's Disease Published in JAMA Neurology
19/06/2018
Data Previously Presented in 2017 at the 13th International Conference on Alzheimer's and Parkinson's Diseases (AD/PD) DUBLIN, Ireland, June 19, 2018 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a [...]
Verrica Pharmaceuticals Inc. Announces Closing of Initial Public Offering
19/06/2018
WEST CHESTER, Pa., June 19, 2018 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq:VRCA), a pharmaceutical company focused on identifying, developing and commercializing innovative pharmaceutical [...]
TiGenix: Transparency notifications pursuant to Article 14 of the Law of May 2, 2007
19/06/2018
REGULATED INFORMATION PRESS RELEASE Transparency notifications pursuant to Article 14 of the Law of May 2, 2007 Leuven (Belgium) - June 19, 2018, 22:00h CET - TiGenix NV (Euronext Brussels and Nasdaq: TIG; "TiGenix") [...]
Biogen to Host Investor Webcast on Its Efforts Targeting Stroke on June 28, 2018
19/06/2018
CAMBRIDGE, Mass., June 19, 2018 (GLOBE NEWSWIRE) -- Biogen (Nasdaq:BIIB) today announced it will host a live webcast providing an overview of its efforts targeting acute ischemic stroke on Thursday, June 28, 2018. The [...]

Pages